Toggle navigation
Home
Search
Services
Blog
Contact
About
13 Week Oral Subchronic Toxicity in Rats & Dogs Applied
Levin, Barry
University of Illinois at Chicago, Chicago, IL, United States
Search 87 grants from Barry Levin
Search grants from University of Illinois at Chicago
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Genetics of Chd Factors in Japanese Americans
Agrin Signaling at the Neuromuscular Synapse
Diabetes Control and Complications Trial
Angiotensin in Brain
SHF: Small:Enabling Practical, Secure, and Physically Unclonable Cryptographic Systems
Recently added grants:
Referral Ctr-Animal models of human genetic disease
Regulation of alveolar epithelial regeneration by T cells
Impact of the Intestinal Microbiome on HIV/SIV Vaccines
Administrative and Faculty Development Core
Transgenic Animal Genotyping and Phenotyping Core
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Prevention And Control (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN015352-001
Application #
3617530
Study Section
Project Start
1991-09-30
Project End
Budget Start
1991-09-30
Budget End
1993-09-29
Support Year
Fiscal Year
1991
Total Cost
Indirect Cost
Institution
Name
University of Illinois at Chicago
Department
Type
Schools of Medicine
DUNS #
121911077
City
Chicago
State
IL
Country
United States
Zip Code
60612
Related projects
NIH 1992
N01 CN
13 Week Oral Subchronic Toxicity in Rats & Dogs Applied
Levin, Barry / University of Illinois at Chicago
NIH 1992
N01 CN
Preclinical Toxicology Studies Ws#24 and #25
Levine, Barry S. / University of Illinois at Chicago
NIH 1991
N01 CN
13 Week Oral Subchronic Toxicity in Rats & Dogs Applied
Levin, Barry / University of Illinois at Chicago
Publications
Crowell, James A; Page, John G; Levine, Barry S et al.
(2006)
Indole-3-carbinol, but not its major digestive product 3,3'-diindolylmethane, induces reversible hepatocyte hypertrophy and cytochromes P450.
Toxicol Appl Pharmacol 211:115-23
Comments
Be the first to comment on Barry Levin's grant